http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112662645-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112662645-B |
| titleOfInvention | Sphingomyelinase D mutant and application thereof |
| abstract | The invention belongs to the technical field of enzyme genetic engineering, and discloses a sphingomyelinase D mutant and application thereof, wherein the sphingomyelinase D mutant is obtained by mutating 78 th cysteine or 84 th cysteine on the basis of a parent sequence of sphingomyelinase D (Laz-SMD) (amino acid sequence SEQ ID NO:1) from Loxoscelesarizonita. The invention provides a method for producing lysophosphatidic acid by hydrolyzing lysophosphatide by utilizing Laz-SMD, which further improves the utilization value of the enzyme in the field of medicines. |
| priorityDate | 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 494.